NLM Logo

ICBV regimen MeSH Supplementary Concept Data 2025


MeSH Supplementary
ICBV regimen
Unique ID
C484812
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C484812
Registry Numbers
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Carmustine
Cyclophosphamide
Etoposide
Idarubicin
Frequency
1
Note
chemotherapy protocol consisting of above compounds; used in the treatment of multiple myeloma
Source
Int J Hematol 2004 Jan;79(1):85-91
Date of Entry
2004/05/06
Revision Date
2004/05/06
ICBV regimen Preferred
page delivered in 0.003s